menopause

February 2025 Drug Safety Part 2: FDA REMS news; Abilify; Isoniazid; Ongentys for Parkinson's; Osphena for menopause

Dear Readers: We normally publish this newsletter every two weeks, but because of a two-week pause in FDA Safety Labeling Change posting activity…

Feb 16

September 2024 Part 2 Drug Safety Updates: Veozah and liver injury, 4 autoimmune drugs, glaucoma drops, weight loss med and heart rate

Consumer-friendly summaries of new safety information added to FDA drug labels

Sep 22, 2024

Drug Safety Updates: February 2024 Part 2

Label updates for estradiol and other menopausal hormone therapy products; fluconazole (diflucan); Vytorin; Warning from Public Citizen on PPIs

Feb 18, 2024 •

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts